Executives On Emerging Markets: Abbott, Merck, Pfizer
This article was originally published in PharmAsia News
Executive Summary
Although Ian Read and Adam Schechter shed little light on the first quarter performance of their respective companies in emerging markets, Miles White went on at length about the need for balance and how currencies would impact guidance.